Related Experiment Video
Updated: Apr 30, 2026

Murine Model of Allergen Induced Asthma
Published on: May 14, 2012
Effects of stingless bee propolis on experimental asthma
José Hidelbland Cavalcante de Farias1, Aramys Silva Reis1, Marcio Antonio Rodrigues Araújo1
1Laboratory of Immunophysiology, Department of Pathology, Biological and Health Sciences Center, Federal University of Maranhão (UFMA), 65085-580 São Luís, MA, Brazil.
This study shows that a propolis hydroalcoholic extract (PHE) from Scaptotrigona aff. postica bees effectively reduced asthma symptoms in mice. PHE treatment decreased inflammatory cells and improved lung pathology, similar to dexamethasone.
Area of Science:
- Immunology
- Pharmacology
- Zoology
Background:
- Bee products, including propolis, have a long history of empirical use for respiratory ailments.
- Asthma is a chronic inflammatory airway disease characterized by airway hyperresponsiveness and reversible airflow obstruction.
Purpose of the Study:
- To investigate the therapeutic potential of a propolis hydroalcoholic extract (PHE) from Scaptotrigona aff. postica stingless bees in a murine model of asthma.
- To evaluate the effects of PHE on inflammatory cell infiltration and cytokine profiles in an ovalbumin-induced asthma model.
Main Methods:
- BALB/c mice were sensitized and challenged with ovalbumin (OVA) to induce an asthma-like condition.
- Mice received daily treatment with PHE (50 or 200 mg/kg) or dexamethasone for two weeks.
- Bronchoalveolar lavage fluid (BALF) cell counts, serum cytokine levels (interferon-gamma), and lung histology were analyzed.
Main Results:
- PHE treatment significantly reduced the total number of inflammatory cells in BALF compared to the control group.
- Histological examination revealed decreased peribronchovascular inflammation and reduced infiltration of polymorphonuclear cells in PHE-treated mice.
- Serum levels of interferon-gamma (IFN-γ) were significantly lowered following PHE administration.
Conclusions:
- Propolis hydroalcoholic extract from Scaptotrigona aff. postica demonstrates significant anti-asthmatic properties in a murine model.
- PHE effectively mitigates airway inflammation by inhibiting inflammatory cell migration and reducing systemic allergic responses.
- These findings suggest PHE as a potential natural therapeutic agent for managing asthma, comparable in efficacy to dexamethasone.
Related Concept Videos
Asthma I: Introduction
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma-I: Introduction
Antiasthma Drugs: β2-Adrenoceptor Agonists
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...

